The National Law Journal has named Crowell & Moring partner Anne Elise Herold Li to its 2023 list of Emerging Therapies/Life Sciences Trailblazers. The list features lawyers who are “agents of change” and have made significant marks on their sector.
Co-chair of Crowell’s Life Sciences Group, Li frequently advises biotech, biologics, pharmaceutical, medical device, and technology companies on all aspects of intellectual property law—patents, trade secrets, unfair competition, trademarks, contract disputes, and licenses. Li advocates for her clients in district court, at the International Trade Commission, at the U.S. Patent and Trademark Office, or anywhere the case takes her. She has successfully represented companies in bet-the-company litigations, scoring key wins long before trial, resulting in favorable settlements.
To see the full list of Emerging Therapies/Life Sciences Trailblazers, visit here.
About Crowell & Moring LLP
Crowell & Moring is an international law firm with operations in the United States, Europe, MENA, and Asia. Drawing on significant government, business, industry and legal experience, the firm helps clients capitalize on opportunities and provides creative solutions to complex litigation and arbitration, regulatory and policy, and corporate and transactional issues. The firm is consistently recognized for its commitment to pro bono service as well as its programs and initiatives to advance diversity, equity and inclusion.
